Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

A single, high-dose treatment of cyclophosphamide stabilized or improved function in multiple sclerosis patients with moderate to severe disease that did not respond to prior trials of immunomodulatory or immunosuppressive drugs.

High-Dose Cyclophosphamide in MS